1. Home
  2. RPID vs BSEM Comparison

RPID vs BSEM Comparison

Compare RPID & BSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$0.95

Market Cap

84.8M

Sector

Health Care

ML Signal

HOLD

Logo BioStem Technologies Inc. Common Stock

BSEM

BioStem Technologies Inc. Common Stock

N/A

Current Price

$2.45

Market Cap

76.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RPID
BSEM
Founded
2006
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.8M
76.9M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
RPID
BSEM
Price
$0.95
$2.45
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $5.75
N/A
AVG Volume (30 Days)
★ 344.3K
156.4K
Earning Date
11-06-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 2.78
N/A
EPS
★ N/A
N/A
Revenue
★ $33,587,000.00
N/A
Revenue This Year
$16.95
N/A
Revenue Next Year
$17.92
$87.68
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 19.74
N/A
52 Week Low
$0.91
$2.25
52 Week High
$4.94
$5.44

Technical Indicators

Market Signals
Indicator
RPID
BSEM
Relative Strength Index (RSI) 22.99 29.62
Support Level N/A $2.25
Resistance Level $2.18 $4.12
Average True Range (ATR) 0.08 0.49
MACD 0.00 -0.19
Stochastic Oscillator 13.45 0.68

Price Performance

Historical Comparison
RPID
BSEM

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

About BSEM BioStem Technologies Inc. Common Stock

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

Share on Social Networks: